Global Value & Access Director - Autoimmune Cell Therapy

Kite Pharma, Inc.

Thousand Oaks (CA)

Hybrid

USD 180,000 - 240,000

Full time

8 days ago

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Kite Pharma, Inc. seeks a Director of Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune. This leadership role reports to the Senior Director and leads global market access efforts across development stages.

The position is office-based/hybrid with 3 onsite days in CA locations including El Segundo, Thousand Oaks, or Foster City. The role requires strategic partnerships with Clinical Development, Medical Affairs, and HE teams to advance access strategies and prepare for future

Qualifications

  • Lead the development and execution of global market access strategies for autoimmune cell therapies.
  • Collaborate with Clinical Development, Medical Affairs, and commercial teams to support launches.
  • Navigate early and late-stage programs to optimize value and access across markets.

Responsibilities

  • Develop and implement global value and access strategies for the autoimmune cell therapy portfolio.
  • Partner with cross-functional teams to prepare for future launches of transformative therapies.
  • Provide strategic insights to enable access and payer discussions for global markets.

Job description

Kite Pharma, Inc. seeks a Director of Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune. This leadership role reports to the Senior Director and leads global market access efforts across development stages.

The position is office-based/hybrid with 3 onsite days in CA locations including El Segundo, Thousand Oaks, or Foster City. The role requires strategic partnerships with Clinical Development, Medical Affairs, and HE teams to advance access strategies and prepare for future

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global Value & Access Director, Autoimmune Cell Therapy
Global Value & Access Director, Autoimmune Cell Therapy

1110 Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 226,000 - 293,000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Global Value & Access Director, Autoimmune Cell Therapies
Global Value & Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 206,000 - 293,000
Medical insurance
Dental insurance
Vision insurance
+2
Global Access Director, Autoimmune Cell Therapies
Global Access Director, Autoimmune Cell Therapies

Kite Pharma, Inc. • San Francisco (CA)

Hybrid
USD 226,000 - 293,000
Director, Global Value & Access (Cell Therapy) – Hybrid
Director, Global Value & Access (Cell Therapy) – Hybrid

Gilead Sciences Inc. • El Segundo (CA)

Hybrid
USD 206,000 - 266,000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • Thousand Oaks (CA)

Hybrid
USD 180,000 - 240,000
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 206,000 - 293,000
Medical insurance
Dental insurance
Vision insurance
+2
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)
Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

1110 Kite Pharma, Inc. • El Segundo (CA)

Hybrid
USD 226,000 - 293,000
Benefits package
Discretionary bonus
Stock-based long-term incentives
+1
Director, US Payer & Value Marketing — CAR-T Access Strategy
Director, US Payer & Value Marketing — CAR-T Access Strategy

Kite Pharma • Santa Monica (CA)

Hybrid
USD 206,000 - 266,000
Discretionary annual bonus
Discretionary stock-based incentives
Paid time off
+1
Global Autoimmune CAR-T Medical Affairs Director
Global Autoimmune CAR-T Medical Affairs Director

Bristol-Myers Squibb Co • New Jersey

Hybrid
USD 207,000 - 251,000
Flexible Time Off
11 paid company holidays
Volunteer days
+1
Global Regulatory Director - Remote Autoimmune Cell Therapy
Global Regulatory Director - Remote Autoimmune Cell Therapy

Kyverna Therapeutics • United States

Remote
USD 300,000 - 600,000